Hepatologist under redar for stating Ayurveda as Pseudoscience

Published On 2022-02-09 11:21 GMT   |   Update On 2022-02-09 11:21 GMT

A Kochi-based hepatologist came under the radar of the Kerala State Medical Council for Indian Systems Of Medicine after he gave a controversial interview where he allegedly claimed that the use of certain herbs such as Giloy (chittamruthu) can be harmful to the liver. The doctor also allegedly called the traditional branch of medicine called Ayurveda, a 'pseudoscience'. This came after the...

Login or Register to read the full article

 A Kochi-based hepatologist came under the radar of the Kerala State Medical Council for Indian Systems Of Medicine after he gave a controversial interview where he allegedly claimed that the use of certain herbs such as Giloy (chittamruthu) can be harmful to the liver. The doctor also allegedly called the traditional branch of medicine called Ayurveda, a 'pseudoscience'.

This came after the doctor gave an interview to a Malayalam YouTube channel and talked about Herb-Induced Liver Injuries in June of last year. During his interview, he explained how the use of certain herbs such as Giloy (chittamruthu), which is also used as a treatment measure, can be harmful to the liver. Speaking to TNM, he said that he did not make illogical claims and has given examples of published evidence regarding all pseudoscientific practices and specifically some herbal drugs which are toxic to the liver. "I specifically spoke about Giloy, which is very liver toxic, based on a paper from Jaslok Hospital and Research Centre, Bombay. 

For more information, check out the full story on the link below:

Kerala based hepatologist lands in soup for defaming Ayurveda and stating it as Pseudoscience


Tags:    

Disclaimer: This site is primarily intended for healthcare professionals. Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement/treatment or prescription. Use of this site is subject to our terms of use, privacy policy, advertisement policy. © 2024 Minerva Medical Treatment Pvt Ltd

Our comments section is governed by our Comments Policy . By posting comments at Medical Dialogues you automatically agree with our Comments Policy , Terms And Conditions and Privacy Policy .

Similar News